Skip to main content
. 2024 Oct 28;5(6):1144–1153. doi: 10.1002/jha2.1035

FIGURE 5.

FIGURE 5

Time to the next treatment (TTNT) for (A) SCT‐E patients and (B) SCT‐NE patients: 2017–2022 versus 2012–2017. 1m, maintenance therapy; 1L, first‐line; 2L, second‐line; 3L, third‐line; 4L, fourth‐line; SCT‐E, eligible; SCT‐NE, noneligible.